To evaluate the frequency of malignancies in Italian patients with systemic sclerosis (SSc) and anti-RNA polymerase III (RNAP III), antitopoisomerase I (topo I), or anticentromere antibodies (ACA); and to characterize the temporal relationship between the 2 diseases, in order to confirm data suggesting a close temporal relationship between the onset of SSc and malignancy in American patients with anti-RNAP III antibodies.

Malignancies in Italian patients with systemic sclerosis positive for anti-RNA polymerase III antibodies

Ceribelli, Angela;
2011-01-01

Abstract

To evaluate the frequency of malignancies in Italian patients with systemic sclerosis (SSc) and anti-RNA polymerase III (RNAP III), antitopoisomerase I (topo I), or anticentromere antibodies (ACA); and to characterize the temporal relationship between the 2 diseases, in order to confirm data suggesting a close temporal relationship between the onset of SSc and malignancy in American patients with anti-RNAP III antibodies.
2011
Adult
Aged
Antibodies, Anti-Idiotypic
Antibodies, Antinuclear
Breast Neoplasms
Carcinoma, Ductal, Breast
Carcinoma, Squamous Cell
Cohort Studies
Comorbidity
DNA Topoisomerases, Type I
Esophageal Neoplasms
Female
Follow-Up Studies
Humans
Italy
Lymphoma, Non-Hodgkin
Male
Middle Aged
Neoplasms
Prevalence
RNA Polymerase III
Retrospective Studies
Scleroderma, Systemic
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11699/68528
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 87
  • ???jsp.display-item.citation.isi??? 73
social impact